The American Society of Hematology's annual meeting taking place Dec. 5 to Dec. 8 in Orlando, Florida. Read More »

PharMerica Corp. announced Thursday that it has completed its acquisition of Luker Pharmacy Management, although terms were not publicly disclosed. Read More »

Johnson & Johnson said this week it has entered a deal to acquire hepatitis B virus (HBV) drug developer Novira Therapeutics Inc. by the end of the year. Read More »

Maine residents will now have easy access to high-quality medical care with the opening of the first MinuteClinics in the state this week. Read More »

U.S.-based drugmaker Pfizer said this week it is tackling the rising costs of prescription medicines head on by expanding its patient assistance program so that more people can gain access to free medicines. Read More »

CVS/pharmacy said Monday its customers can show their support for groundbreaking cancer research by participating in its second annual in-store fundraising campaign to benefit Stand Up To Cancer (SU2C). Read More »

A report released Tuesday by the Generic Pharmaceutical Association (GPhA) indicates generic drugs generated significant savings for all stakeholders in the health care industry in 2014 and over the past decade. Read More »

Dallas-based oncology drug development company Arog Pharmaceuticals, Inc. named Ada Braun senior vice president of clinical development on Monday. Read More »

The cancer-fighting drug Imbruvica (ibrutinib) recently received the 2015 Prix Galien Award for Best Pharmaceutical Agent. Read More »

New Haven Pharmaceuticals said data on the antiplatelet effects of Durlaza will be presented in a poster session during the American Heart Association Scientific Sessions that begin this weekend in Orlando, Florida. Read More »

CVS Health said Monday it will be expanding its Registered Apprenticeship program to include new markets and fields of study. Read More »

Use of prescription drugs among adults in the United States has drastically increased since the turn of the 21st century, a study published Tuesday in the Journal of the American Medical Association said. Read More »

The pharmaceutical industry is being forced to undergo an extensive transformation as the serialization of prescription medicine packages to verify the origins of a given medicine will be mandatory in all European Union countries by 2019. Read More »

Bristol-Myers Squibb has entered into a deal to acquire all issued and outstanding capital stock of Cardioxyl Pharmaceuticals, Inc. Read More »

The FDA has granted priority review of Acadia Pharmaceuticals' new drug application (NDA) for Nuplazid (pimavanserin) that is intended to treat Parkinson's disease psychosis. Read More »

The American Society of Health-System Pharmacists (ASHP) said legislation pending in the U.S. House of Representatives that would help the medically underserved needs four more co-sponsors to get to the next phase. Read More »

AstraZeneca and Eli Lilly and Co. said recently they will expand their present immuno-oncology collaboration to develop innovative combination therapy options for patients with solid tumors. Read More »

The U.S. Food and Drug Administration approved Strensiq (asfotase alfa) to treat perinatal, infantile and juvenile-onset hypophosphatasia (HPP), a rare, genetic, progressive, metabolic disease. Read More »

The U.S. Food and Drug Administration (FDA) recently approved Veltassa (patiromer for oral suspension) to treat patients with elevated levels of potassium in the blood, a condition known as hyperkalemia. Read More »

The U.S. Department of Health and Human Services Office of Inspector General said recently the federal Medicaid program could have realized savings if New York had applied medical loss ratio standards like those set in the Affordable Care Act (ACA). Read More »